HIV concerns round contraception jab

Comment on this story
syringe sxc The drug is administered through an injection every two weeks and costs �5,600 a month. Picture: Supplied

South Africa's most commonly used injectable contraceptives may be phased out, because of concerns about HIV, City Press reported on Sunday.

It reported that Depo-Provera and Nuristerate, which are both injectable, were the most commonly used contraceptives in South Africa.

According to a recent study by the Wits Reproduction Health and HIV Institute, there was a possible link between injectable hormonal contraceptives and an increased risk of HIV infection.

Using Depo-Provera doubled a woman's risk of transmitting the virus to her partner, the study found.

Health department spokesman Fidel Hadebe told City Press that the department was discussing proposed changes to contraceptive policy made in the report.

Professor Helen Rees, the institute's head, told the weekly newspaper more research was needed on the link between Depo-Provera and HIV.

Nevertheless, newer contraceptive methods, with fewer side effects, could be phased in, she said.

“It is very important that a wider range of contraceptives are made available to women before removing Depo from family planning clincs.” - Sapa

For support and fun on your parenting journey, join our Babynet forum....

Get our free Lifestyle newsletter - subscribe here...

sign up

Comment Guidelines

  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

  5. Verified email addresses: All users on Independent Media news sites are now required to have a verified email address before being allowed to comment on articles. You are only required to verify your email address once to have full access to commenting on articles. For more information please read our comment guidelines